Screener
Immunovant, Inc. IMVT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | Years Ended March 31, 2026 | Years Ended March 31, 2025 | Years Ended March 31, 2024 |
|---|---|---|---|
| Net cash used in operating activities | (407,310) | (375,874) | (214,227) |
| Cash flows from investing activities | |||
| Purchases of property and equipment | (8) | (759) | (360) |
| Net cash used in investing activities | (8) | (759) | (360) |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock upon underwritten offering, net of underwriter discounts and commissions, and private placement | 544,194 | 450,000 | 472,745 |
| Payment of offering and private placement costs | (504) | (319) | (6,012) |
| Proceeds from stock options exercised | 52,066 | 4,811 | 5,694 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s investing cash flow?
- Immunovant, Inc. (IMVT) reported investing cash flow of -$8K in Q1 2026.
- How has Immunovant, Inc.'s investing cash flow changed year-over-year?
- Immunovant, Inc.'s investing cash flow increased by 96.0% year-over-year, from -$201K to -$8K.
- What is the long-term trend for Immunovant, Inc.'s investing cash flow?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s investing cash flow has grown at a -57.9% compound annual growth rate (CAGR), from -$254K to -$8K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Immunovant, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude